Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis. In regard to Lee et al.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Quantitative Characterization of Tumor Proximity to Stem Cell Niches: Implications on Recurrence and Survival in GBM Patients.International journal of radiation oncology, biology, physics · 2021
   Article
2. Hippocampal sparing radiotherapy for glioblastoma patients: a planning study using volumetric modulated arc therapy.Radiation oncology (London, England) · 2016
   Article
3. Neural stem cells, the subventricular zone and radiotherapy: implications for treating glioblastoma.Journal of neuro-oncology · 2016
   Review

Corrections and comments

• Commented on by
  In reply to Sharma et al.2013
• Comment on
  Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis.2013

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as